Both in Pharmaceuticals
InMed Pharmaceuticals vs Gain Therapeutics
Over the past year INM returned +405.8% and GANX returned −33.1%; their daily moves had a correlation of -0.02.
INM +405.8% GANX −33.1%Growth of $1, one year, split-adjusted
| Metric | INM | GANX |
|---|---|---|
| Price | $8.75 | $1.11 |
| Market cap | $48.1M | $48.4M |
| Today | +420.83% | −3.48% |
| 1 month | +557.9% | −33.5% |
| 6 months | +1104.6% | −41.9% |
| Year to date | +725.5% | −65.5% |
| 1 year | +373.0% | −39.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 24.8× | — |
| Net cash | $2.2M | $12.7M |
| Dividend yield | — | — |
| Volatility (60d) | 338.3% | 55.4% |
| Short % of float | 0.1% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).